Literature DB >> 15927732

Granisetron attenuates exercise-induced conditioned taste aversion in the rat.

S Eccles1, E-M Kim, E O'Hare.   

Abstract

A conditioned taste aversion (CTA) paradigm was used in the present study to investigate whether CTA produced by exercise could be attenuated by the 5-HT(3) receptor antagonist granisetron. Male Sprague-Dawley rats were randomly allocated to one of four groups (Ns=6) and were exposed to salty (0.128 M sodium chloride) or sour (0.00138M citric acid) solutions. Subjects were injected with either saline solution (1.0 ml, 0.9%) or granisetron (0.5mg/kg, IP) and were exposed to 30 min of forced wheel running exercise (70 revolutions/30min) 10 min after injection. Exercise induced CTA to both the salty (3.7 ml intake) and sour-flaroured (3.1ml intake) solutions as compared with no exercise (intake 14.0 and 13.7 ml), and administration of granisetron significantly attenuated the exercise-induced CTA to the salty- and sour-flavoured solutions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927732     DOI: 10.1016/j.appet.2005.02.001

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  3 in total

1.  Running-based pica and taste avoidance in rats.

Authors:  Sadahiko Nakajima
Journal:  Learn Behav       Date:  2018-06       Impact factor: 1.986

2.  Mammalian Taste Bud Cells Utilize Extragemmal 5-Hydroxy-L-Tryptophan to Biosynthesize the Neurotransmitter Serotonin.

Authors:  Hong-Ru Pan; Miao Tian; Jian-Bo Xue; Song-Min Li; Xiao-Cui Luo; Xiao Huang; Zhen-Huang Chen; Liquan Huang
Journal:  Front Cell Neurosci       Date:  2018-11-26       Impact factor: 5.505

3.  A Handful of Details to Ensure the Experimental Reproducibility on the FORCED Running Wheel in Rodents: A Systematic Review.

Authors:  Daniel Garrigos; Marta Martínez-Morga; Angel Toval; Yevheniy Kutsenko; Alberto Barreda; Bruno Ribeiro Do Couto; Fernando Navarro-Mateu; José Luis Ferran
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.